0000950170-24-005533.txt : 20240118
0000950170-24-005533.hdr.sgml : 20240118
20240118185100
ACCESSION NUMBER: 0000950170-24-005533
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240116
FILED AS OF DATE: 20240118
DATE AS OF CHANGE: 20240118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BAFFI ROBERT
CENTRAL INDEX KEY: 0001274826
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36327
FILM NUMBER: 24543314
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Neurogene Inc.
CENTRAL INDEX KEY: 0001404644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980542593
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 535 W 24TH STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: (877) 237-5020
MAIL ADDRESS:
STREET 1: 535 W 24TH STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10011
FORMER COMPANY:
FORMER CONFORMED NAME: Neoleukin Therapeutics, Inc.
DATE OF NAME CHANGE: 20190812
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS, INC
DATE OF NAME CHANGE: 20140128
FORMER COMPANY:
FORMER CONFORMED NAME: AQUINOX PHARMACEUTICALS (USA) INC
DATE OF NAME CHANGE: 20070626
4
1
ownership.xml
4
X0508
4
2024-01-16
0001404644
Neurogene Inc.
NGNE
0001274826
BAFFI ROBERT
C/O NEUROGENE INC.
535 W 24TH STREET, 5TH FLOOR
NEW YORK
NY
10011
true
false
false
false
false
Stock Option (Right to Buy)
32.30
2024-01-16
4
A
false
15400
0.00
A
2034-01-16
Common Stock
15400
15400
D
This option represents the right to purchase 15,400 shares of common stock of the Issuer, and vests in equal monthly installments through January 16, 2027, subject to the reporting person's continued service to the Issuer through each applicable vesting date.
/s/ Christine Mikail, as attorney-in-fact for Robert Baffi
2024-01-18